Saturday, July 30, 2016

Delivra implementing U.S. expansion strategy for topical creams

Delivra implementing U.S. expansion strategy for topical creams

May 24, 2016 by · Leave a Comment 

Tweet The major initiative for Delivra (TSX-V:DVA) in 2016 is to introduce its flagship LivRelief topical pain and nerve creams to the U.S. market, initially through a U.S. web store and Amazon, and then through regional and national retailers, such as Walmart, Walgreens and CVS. “We are launching an aggressive digital campaign shortly, and later […]

In conversation with Paul Gunn

In conversation with Paul Gunn

April 26, 2016 by · Leave a Comment 

http://www.youtube.com/watch?v=Acau04X2Utk’]

Tweet As president and CEO of closely-held Soricimed Biopharma, Paul Gunn parlayed a 20-year career as a financial executive into funding the startup of Soricimed along with a tech transfer in 2005 facilitated by Mount Allison University in Sackville, New Brunswick, Canada. Admittedly, he was new to biotech and drug development in those days, but […]

NovellusDx expands board, raises $10-million

NovellusDx expands board, raises $10-million

February 19, 2016 by · Leave a Comment 

Tweet Closely-held NovellusDx of Israel has appointed Heiner Dreismann and Dr. Charles Woler to the board. “The appointment of Drs. Dreismann and Woler, both venerated leaders in the biotech and pharma industries, with strong track records of success, is consistent with our effort to bring the best talent to NovellusDx and rapidly become the leader […]

Knight Therapeutics to collaborate with Medison Biotech

Knight Therapeutics to collaborate with Medison Biotech

September 1, 2015 by · Leave a Comment 

Tweet Knight Therapeutics (TSX:GUD) and closely-held Medison Biotech (1995) Ltd. of Israel have entered a strategic collaboration to bring innovative treatments to patients in Canada, Israel and Romania. The companies will maintain a structure that will scan and evaluate the productive Israeli pharma/biotech/device landscape on a regular basis and will provide them with the required […]

Rodman sees higher small-cap biotech valuations

Rodman sees higher small-cap biotech valuations

October 20, 2011 by · Leave a Comment 

Tweet Citing the proposed acquisition of Anadys Pharmaceuticals (NASDAQ:ANDS) by Roche (NASDAQ: RHHBY) at a 260% premium, Rodman & Renshaw figures that Pharma’s strong balance sheet and expiring patents on blockbuster drugs “bring together the perfect storm of factors could lead to higher small-cap biotechnology valuations.” The Roche-Anadys acquisition highlights the “increasing appetite of pharmaceutical […]

RepliCel’s cell-based solution to hair loss

RepliCel’s cell-based solution to hair loss

October 18, 2011 by · Leave a Comment 

http://www.youtube.com/watch?v=cCe5mg7X6zg&feature=youtu.be’]

Tweet After two decades of research and collaboration, RepliCel Life Sciences (OTCBB: REPCF) in the first quarter next year will learn whether its natural hair cell replication technology has the potential to become the world’s first, minimally invasive solution for pattern baldness and general hair loss in men and women. “Our autologous cell implantation technology […]

Cangene discloses development of IGIV

Cangene discloses development of IGIV

June 14, 2010 by · Leave a Comment 

Tweet Cangene (TSX:CNJ) is developing an immune globulin intravenous product, commonly known as IGIV, which is a widely used anti-infective with a variety of indication, including primary immune deficiency, immune thrombocytopenic purpura and other inflammatory and autoimmune diseases. Cangene is increasing its R&D activities on this product as it moves toward clinical development and is […]

Medicago in vaccine MOU in Indonesia

Medicago in vaccine MOU in Indonesia

June 14, 2010 by · Leave a Comment 

Tweet Medicago (TSX:MDG) has signed a memorandum of understanding with Indonesia’s PT Bio Farma to develop select vaccine targets of mutual interest, with the final goal of establishing a partnership to build a Medicago plant-based manufacturing facility in the country. “This agreement confirms the suitability of our technology to support vaccine development in countries where […]

TSO3 to resubmit for U.S. clearance

TSO3 to resubmit for U.S. clearance

June 8, 2010 by · Leave a Comment 

Tweet TSO3 (TSX:TOS) has received instructions from U.S. regulatory authorities to resubmit a 510k for its Sterizone 125L + Sterilizer with “additional data” and to “better establish the link between the sterilizer and a variety of accessory products used in the sterilizer,” which are also subject to 510k clearance and have been previously submitted. “TSO3 […]

Versant ups CML to buy

Versant ups CML to buy

June 7, 2010 by · Leave a Comment 

Tweet Versant Partners upgraded CML Healthcare (TSX:CLC.UN) to “buy” from “neutral,” saying that the price of the units has fallen markedly in recent weeks, “unjustified by core fundamentals in our view.” Analyst Doug Loe kept his target price unchanged at $12. The units closed Friday at $9.70. They were quoted at nearly $13 at the […]

Next Page »

Email Newsletters with Constant Contact
Google+